Covid-19 has served as a timely reminder of how crucial vaccines are to public health: a vaccine offers the best chance of stopping this global pandemic. And, whilst it typically takes between 10 and 15 years to research, develop and establish the safety and efficacy of a novel vaccine, a globally accessible vaccine for covid-19 could be ready within the next 6 to 12 months.
During this virtual panel discussion hosted by The Economist, a panel of experts will discuss what has and will make this delivery at record speed possible. They will highlight some of the key factors behind this rapid response as well as identify and assess solutions to possible roadblocks that may come up in the coming months. Chaired by an Economist editor the panel will also examine what happens after the vaccine has been developed. How can we ensure that the vaccine gets to all those that need it in Asia-Pacific? What is being done to ensure the rapid and efficient production of the potential vaccine? And, what does this mean for the future of the vaccine market more broadly?
About the Organizers
Visited 10 times, 1 Visit today